Efficient control of leukemia with treatment by dual immune-checkpoint blockade

Posted on

Preclinical study of antibody-based immunotherapy

Source: Luxembourg Institute of Health

Summary: Chronic #lymphocytic #leukemia (CLL) is a hematological #malignancy. When infiltrating tissues, CLL cells come in contact with healthy cells, including immune cells. Researchers have now characterized the composition of #immune #cells and circulating cytokines of the CLL microenvironment in mouse models using mass cytometry. Based on this knowledge, they propose an immunotherapeutic strategy with two immune checkpoint inhibitors that efficiently blocks disease development in preclinical tests.

Contact us by E-mail: editor.jceog@scitechnol.com or Online Submissison


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s